| |
| |
|
| Insider
Information: |
Clancy Paul J |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
138,295 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,757,220 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,295 |
|
|
| Total
Value |
$20,757,220 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Executive VP and CFO |
2017-04-25 |
10,813 |
|
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Financial O... |
2019-07-11 |
90,447 |
2017-07-10 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2024-03-28 |
15,785 |
2019-03-29 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
6,549 |
2019-05-31 |
0 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
14,701 |
2021-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2017-02-28 |
4 |
D |
$274.76 |
$853,135 |
D/D |
(3,054) |
30,596 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2014-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,191 |
10,278 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2015-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,191 |
18,646 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2016-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,194 |
25,451 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,521 |
47,618 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,599 |
14,701 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2016-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,859 |
27,768 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2008-07-01 |
4 |
AS |
$56.01 |
$235,679 |
D/D |
(4,208) |
37,502 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2014-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,280 |
17,473 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,281 |
32,720 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,299 |
22,960 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2014-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,691 |
13,922 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2015-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,691 |
22,194 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,692 |
30,170 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-07-11 |
4 |
D |
$124.20 |
$649,566 |
D/D |
(5,230) |
90,447 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2018-07-10 |
4 |
S |
$131.11 |
$687,148 |
D/D |
(5,241) |
93,309 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,606 |
11,102 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-02-07 |
4 |
D |
$119.57 |
$715,148 |
D/D |
(5,981) |
87,328 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2008-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
43,237 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2018-02-08 |
4 |
S |
$116.31 |
$707,048 |
D/D |
(6,079) |
89,014 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,780 |
31,948 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFO |
• – – |
2007-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
32,395 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-04-29 |
4 |
AS |
$219.71 |
$2,004,414 |
D/D |
(9,123) |
21,576 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,428 |
95,677 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,536 |
98,550 |
0 |
- |
|
119 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
